MassDevice.com +5 | The top 5 medtech stories for April 5, 2017

Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in your inbox everyday by subscribing to our newsletters.   5. Trumpcare’s prospects dim, but not too dim to hit stent graft makers The push on Capitol Hill to revive Trumpcare stalled yesterday, but not before the chatter out of Washington instigated a slide for stent graft makers’ stocks. The Affordable Care Act covers a 1-time screening for abdominal aortic aneurysms in men who smoke or smoked in the past, listing the test as an “essential health benefit.” Read more 4. Mazor Robotics slides on Q1 prelims Share prices for Mazor Robotics slid today despite preliminary 1st-quarter sales numbers that beat expectations on Wall Street. The Caesarea, Israel-based robot-assisted surgery device maker said it expects to post sales of $11.5 million for the 3 months ended March 31, ahead of The Street’s $11.2 million forecast and up 79.7% compared with Q1 2016. Investors reacted by sending MZOR shares down -1.6% to $29.11 apiece today in late-morning trading. Analysts are looking for Q1 losses per share of -21¢ and full-year losses of -81¢ on sales of $51.9 million. Read more 3. Medtronic issues field safety notice for Newpo...
Source: Mass Device - Category: Medical Equipment Authors: Tags: News Well Plus 5 Source Type: news